State Stem Cell Agency ICOC Agenda 1-29-09

Jan 29, 2009
Main Location: 

Crowne Plaza Hotel SFO
1177 Airport Blvd
Burlingame, CA 94010

Additional Locations: 
409 North Larchmont Blvd Los Angeles, CA 90004

California State Stem Cell Agency

 

REGULAR MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE (“ICOC”)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE


Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Open Session

  1. Call to Order.
  2. Pledge of Allegiance.
  3. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

 

CONSENT ITEMS

  1. Approval of minutes from August 12-13, September 25th and December 9-10 , 2008 ICOC Meetings.
  2. Consideration of Adoption of Regulation 100502, Definition of “California Supplier.”

 

REPORTS

  1. Chairman’s Report.
  2. President’s Report, including but not limited to, updates on operating budget and research funding budget.
  3. Presentation on California budget status and impact on CIRM funding.
  4. Case study of BANs and Potential for Private Placement of Bonds for 2008-09 & 2009-10 fiscal year CIRM budget.

  10.

Presentation on Federal Stimulus Bill and Omnibus Bill and potential benefits for biomedical and stem cell research.
  1. Summary Chart of Stimulus Proposals
  2. Draft Stimulus Bill from US House of Representatives
  3. Report Text of draft Stimulus Bill from US House of Representatives

 

ACTION ITEMS

  11.

Consideration of recommendations from Grants Working Group on Bridges to Stem Cell Research and Training Grant II applications.

 a. Extraordinary Petition: Training Program II Application TG2-01167

  12. Consideration of recommendations from Grants Working Group on Tools & Technology applications.

         a.  Extraordinary Petition: Tools & Technology Awards Application RT1-01073-1

 

CLOSED SESSION

 13. a. Discussion of confidential intellectual property or work product and prepublication, confidential scientific research or data relating to Bridges to Stem Cell Research, Training Grant II, and Tools and Technology applications. (Health & Safety Code 125290.30(d) (3) (B) and (C)).

 

ACTION ITEMS

  14. Public report of any action taken, if necessary, during closed session.

 

DISCUSSION ITEMS

  15. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE. Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice. 

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

 

Transcripts: 

© 2013 California Institute for Regenerative Medicine